|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,248.00 INR | +1.31% |
|
-0.62% | +10.42% |
| 08-03 | Glenmark Pharmaceuticals Limited, Q1 2027 Earnings Call, Aug 03, 2026 | |
| 07-31 | India's Glenmark Pharma posts higher quarterly profit on strong demand | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.22% | -2.51% | +1.42% | +6.55% | +12.81% | +18.87% | +67.13% | +146.77% | +130.43% | 49.54B | |
| -1.75% | +2.61% | +1.07% | +4.84% | +33.04% | +59.16% | +125.42% | +171.82% | +156.80% | 40.07B | |
| -0.08% | -1.05% | -0.92% | +9.38% | -3.47% | -2.73% | +19.22% | +54.31% | +173.57% | 12.4B | |
| -0.79% | -0.14% | -2.33% | +22.89% | +22.61% | +16.75% | +71.11% | +91.77% | +197.69% | 11.85B | |
| +1.72% | -0.38% | +0.38% | +6.53% | +28.57% | +31.82% | +134.08% | +137.27% | +342.30% | 9.1B | |
| -0.26% | -7.65% | -6.02% | -2.52% | +5.91% | +36.44% | -15.53% | -7.27% | -35.74% | 6.88B | |
| +1.46% | +3.76% | -1.30% | -5.45% | +23.06% | +16.06% | +34.29% | +38.58% | +111.50% | 6.94B | |
| -.--% | +0.14% | - | - | - | - | - | - | - | 6.79B | |
| -.--% | -1.95% | - | - | - | - | - | - | - | 5.73B | |
| +2.65% | +3.65% | -14.97% | -33.55% | -31.22% | -31.83% | +14.90% | +22.94% | +22.59% | 5.63B | |
| -2.49% | +1.21% | +1.90% | +18.63% | +24.15% | +30.42% | +96.91% | +127.23% | +182.12% | 4.63B | |
| -0.49% | -5.83% | +0.67% | +3.33% | +1.17% | -5.02% | +76.79% | +34.71% | - | 3.99B | |
| +0.82% | -0.94% | -6.23% | +5.53% | +26.65% | +28.63% | -23.34% | -16.54% | -60.82% | 4.01B | |
| -0.82% | +4.68% | +4.73% | +30.52% | +38.72% | +29.79% | +672.77% | +290.52% | +97.62% | 3.46B | |
| +0.66% | -5.32% | -4.48% | -19.64% | -19.61% | -38.80% | +38.06% | +61.07% | +12.37% | 2.67B | |
| -1.05% | -1.72% | -0.19% | -6.42% | +2.30% | +13.04% | +66.74% | +18.38% | +78.82% | 2.8B | |
| +3.08% | +12.16% | +4.73% | +3.46% | -3.03% | -3.78% | +51.82% | +196.76% | +713.02% | 2.84B | |
| +0.50% | +2.97% | -4.38% | -7.79% | -0.21% | -13.41% | +21.37% | - | - | 2.63B | |
| +5.69% | +19.93% | -21.82% | -59.15% | -28.04% | -14.16% | +149.70% | +192.99% | +1,600.20% | 2.74B | |
| Average | +0.39% | +2.84% | -2.81% | -1.34% | +7.85% | +10.07% | +94.20% | +97.58% | +248.16% | 9.72B | |
| Weighted average by Cap. | -0.50% | +1.95% | -0.72% | +4.09% | +15.64% | +23.98% | +85.70% | +120.80% | +172.85% |
- Stock Market
- Stocks
- GLENMARK Stock
- GLENMARK Stock
- Sector Glenmark Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
